BZAM (OTCMKTS:BZAMF – Get Free Report) and biote (NASDAQ:BTMD – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership and earnings.
Profitability
This table compares BZAM and biote’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| BZAM | N/A | N/A | N/A |
| biote | 14.72% | -21.86% | 15.68% |
Insider & Institutional Ownership
0.0% of BZAM shares are owned by institutional investors. Comparatively, 21.7% of biote shares are owned by institutional investors. 8.7% of BZAM shares are owned by insiders. Comparatively, 24.0% of biote shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| BZAM | $37.96 million | N/A | -$27.31 million | ($0.27) | N/A |
| biote | $197.19 million | 0.62 | $3.16 million | $0.79 | 3.39 |
biote has higher revenue and earnings than BZAM. BZAM is trading at a lower price-to-earnings ratio than biote, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent recommendations for BZAM and biote, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| BZAM | 0 | 0 | 0 | 0 | 0.00 |
| biote | 1 | 1 | 1 | 0 | 2.00 |
biote has a consensus price target of $6.00, suggesting a potential upside of 123.80%. Given biote’s stronger consensus rating and higher possible upside, analysts clearly believe biote is more favorable than BZAM.
Summary
biote beats BZAM on 10 of the 11 factors compared between the two stocks.
About BZAM
BZAM Ltd. operates as a cannabis producer with a focus on branded consumer goods. Its brands include the BZAM, TGOD, ness, Highly Dutch Organic, and TABLE TOP, as well as Dunn Cannabis, FRESH, and Wyld partner brands. The company operate facilities in British Columbia, Alberta, Ontario, and Quebec, as well as retail stores in Winnipeg, Manitoba and Regina, Saskatchewan. The company was formerly known as The Green Organic Dutchman Holdings Ltd. and changed its name to BZAM Ltd. in February 2023. The company was incorporated in 2016 and is headquartered in Vancouver, Canada.
About biote
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Receive News & Ratings for BZAM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BZAM and related companies with MarketBeat.com's FREE daily email newsletter.
